Kissei Pharmaceutical Co Ltd
TSE:4547

Watchlist Manager
Kissei Pharmaceutical Co Ltd Logo
Kissei Pharmaceutical Co Ltd
TSE:4547
Watchlist
Price: 3 765 JPY -0.13% Market Closed
Market Cap: 161.2B JPY

Kissei Pharmaceutical Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kissei Pharmaceutical Co Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Kissei Pharmaceutical Co Ltd
TSE:4547
Net Income (Common)
ÂĄ11.7B
CAGR 3-Years
27%
CAGR 5-Years
20%
CAGR 10-Years
4%
Takeda Pharmaceutical Co Ltd
TSE:4502
Net Income (Common)
ÂĄ208.1B
CAGR 3-Years
-22%
CAGR 5-Years
73%
CAGR 10-Years
15%
Daiichi Sankyo Co Ltd
TSE:4568
Net Income (Common)
ÂĄ245.8B
CAGR 3-Years
38%
CAGR 5-Years
11%
CAGR 10-Years
10%
Otsuka Holdings Co Ltd
TSE:4578
Net Income (Common)
ÂĄ343.1B
CAGR 3-Years
40%
CAGR 5-Years
22%
CAGR 10-Years
9%
Chugai Pharmaceutical Co Ltd
TSE:4519
Net Income (Common)
ÂĄ387.3B
CAGR 3-Years
9%
CAGR 5-Years
20%
CAGR 10-Years
22%
Astellas Pharma Inc
TSE:4503
Net Income (Common)
-ÂĄ57.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Kissei Pharmaceutical Co Ltd
Glance View

Market Cap
161.2B JPY
Industry
Pharmaceuticals

Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. The company is headquartered in Matsumoto-Shi, Nagano-Ken and currently employs 1,863 full-time employees. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The firm is engaged in the collection and analysis of medicine development information, and the manufacture and sale of medicines. The company is also engaged in the purchase and sale of related materials, system development and information process work, construction contract work such as new construction, expansion and renovation of factories, laboratories and offices, the management of facility and equipment work, information collection and development support work, noodle manufacture and sale, and insurance agency business.

Intrinsic Value
2 629.38 JPY
Overvaluation 30%
Intrinsic Value
Price

See Also

What is Kissei Pharmaceutical Co Ltd's Net Income (Common)?
Net Income (Common)
11.7B JPY

Based on the financial report for Dec 31, 2024, Kissei Pharmaceutical Co Ltd's Net Income (Common) amounts to 11.7B JPY.

What is Kissei Pharmaceutical Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
4%

Over the last year, the Net Income (Common) growth was -4%. The average annual Net Income (Common) growth rates for Kissei Pharmaceutical Co Ltd have been 27% over the past three years , 20% over the past five years , and 4% over the past ten years .

Back to Top